157 related articles for article (PubMed ID: 3980806)
21. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
22. The relative importance of risk factors in nonmelanoma carcinoma.
Vitaliano PP; Urbach F
Arch Dermatol; 1980 Apr; 116(4):454-6. PubMed ID: 7369779
[TBL] [Abstract][Full Text] [Related]
23. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
Henseler T; Christophers E; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
[TBL] [Abstract][Full Text] [Related]
24. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
Forman AB; Roenigk HH; Caro WA; Magid ML
Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
[TBL] [Abstract][Full Text] [Related]
27. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation.
Stern RS; Zierler S; Parrish JA
Lancet; 1980 Apr; 1(8171):732-5. PubMed ID: 6103156
[TBL] [Abstract][Full Text] [Related]
28. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
Stern RS; Momtaz K
Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
[TBL] [Abstract][Full Text] [Related]
29. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
30. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
[TBL] [Abstract][Full Text] [Related]
31. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
Nijsten TE; Stern RS
J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
[TBL] [Abstract][Full Text] [Related]
33. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
34. Skin cancer in the PUVA-48 cooperative study.
Roenigk HH; Caro WA
J Am Acad Dermatol; 1981 Mar; 4(3):319-24. PubMed ID: 7217399
[TBL] [Abstract][Full Text] [Related]
35. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
36. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
van Praag MC; Bavinck JN; Bergman W; Rosendaal FR; Mommaas AM; Bruynzeel I; Scheffer E; Vermeer BJ; Bruijn JA
J Am Acad Dermatol; 1993 Mar; 28(3):412-7. PubMed ID: 8445056
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
38. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
deShazo R; Soltani-Arabshahi R; Krishnasamy S; Langley RG; Kalia S; Ståhle M; Langholff W; Goyal K; Fakharzadeh S; Galindo C; Srivastava B; Krueger G
J Drugs Dermatol; 2019 Oct; 18(10):1059-1060. PubMed ID: 31603636
[TBL] [Abstract][Full Text] [Related]
39. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis.
Albergo RP; Gilgor RS
Cutis; 1982 Nov; 30(5):621-4. PubMed ID: 6756797
[TBL] [Abstract][Full Text] [Related]
40. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
